Cutler Group LP Dbv Technologies S.A. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Dbv Technologies S.A. stock. As of the latest transaction made, Cutler Group LP holds 3,100 shares of DBVT stock, worth $9,889. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,100

Previous 3,100 -0.0%

Holding current value

$9,889

Previous $2,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 27, 2020	SELL	$1.58 - $4.77 $2,370 - $7,154	-1,500 Reduced 32.61%	3,100 $5,000
Q2 2020 Jul 22, 2020	BUY	$3.74 - $6.28 $12,342 - $20,724	3,300 Added 253.85%	4,600 $20,000
Q1 2020 May 07, 2020	SELL	$2.33 - $12.98 $3,495 - $19,470	-1,500 Reduced 53.57%	1,300 $5,000
Q4 2019 Feb 06, 2020	BUY	$6.75 - $11.15 $3,375 - $5,575	500 Added 21.74%	2,800 $29,000
Q3 2019 Oct 28, 2019	BUY	$8.57 - $10.72 $19,711 - $24,656	2,300 New	2,300 $19,000
Q4 2018 Feb 05, 2019	SELL	$5.75 - $21.85 $8,050 - $30,590	-1,400 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$16.81 - $24.58 $28,576 - $41,786	-1,700 Reduced 54.84%	1,400 $31,000
Q2 2018 Aug 10, 2018	SELL	$18.6 - $24.94 $9,858 - $13,218	-530 Reduced 14.6%	3,100 $59,000
Q1 2018 May 11, 2018	BUY	$20.86 - $26.6 $44,640 - $56,924	2,140 Added 143.62%	3,630 $83,000
Q4 2017 Jan 17, 2018	BUY	$20.9 - $49.36 $31,140 - $73,546	1,490	1,490 $36,000

Others Institutions Holding DBVT

# of Institutions

Shares Held

3.2K

Call Options Held

Put Options Held

Exane Derivatives

101
Shares

$322
0.0% of portfolio

View Full List

About DBV Technologies S.A.

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $599M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

More about DBVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account